CRISPR Treatment Cuts Cholesterol in Patients

A new CRISPR treatment has shown promising results by cutting 'bad' cholesterol levels in half for patients with difficult-to-treat lipid disorders. After just one dose, the treatment significantly reduced LDL cholesterol and triglycerides, and the effects lasted for a full year. This breakthrough could change how we treat cholesterol-related health issues.

Based on reporting from ScienceDaily. Read the original story →